Stopping Ozempic Suddenly Can Raise Heart Attack, Stroke Risk By 22%: Study
A study found that abruptly stopping Ozempic and other GLP-1 drugs increases the risk of major cardiovascular events by 22% after two years. The research analyzed health records of over 333,000 US veterans with Type 2 diabetes.
What Happened?
A study found that abruptly stopping Ozempic and other GLP-1 drugs increases the risk of major cardiovascular events by 22% after two years. The research analyzed health records of over 333,000 US veterans with Type 2 diabetes.
AI Quick Summary
A study links stopping Ozempic to a 22% higher risk of heart events after two years, emphasizing the need for medical guidance.
Key points
- Abruptly stopping GLP-1 medications like Ozempic raises cardiovascular risk.
- The risk of major heart events increases by 22% after two years off treatment.
- The study analyzed over 333,000 health records of US veterans with Type 2 diabetes.
- Discontinuation for six months raises risk by 4%, and one year by 14%.
- The study highlights the need for medical guidance before stopping medication.
Key insights
- Patients should consult healthcare providers before discontinuing GLP-1 medications.
- The findings may lead to revised treatment plans for Type 2 diabetes management.
- Increased cardiovascular risks could affect long-term health outcomes for patients.
- The study's limitations suggest caution in generalizing results to all GLP-1 users.
Why it matters
This study highlights the cardiovascular risks associated with stopping GLP-1 medications, which is crucial for patients managing Type 2 diabetes.
Source
Times Now
